Cargando…
Heparan sulfate proteoglycans present PCSK9 to the LDL receptor
Coronary artery disease is the main cause of death worldwide and accelerated by increased plasma levels of cholesterol-rich low-density lipoprotein particles (LDL). Circulating PCSK9 contributes to coronary artery disease by inducing lysosomal degradation of the LDL receptor (LDLR) in the liver and...
Autores principales: | Gustafsen, Camilla, Olsen, Ditte, Vilstrup, Joachim, Lund, Signe, Reinhardt, Anika, Wellner, Niels, Larsen, Torben, Andersen, Christian B. F., Weyer, Kathrin, Li, Jin-ping, Seeberger, Peter H., Thirup, Søren, Madsen, Peder, Glerup, Simon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5593881/ https://www.ncbi.nlm.nih.gov/pubmed/28894089 http://dx.doi.org/10.1038/s41467-017-00568-7 |
Ejemplares similares
-
Heparan Sulfate and Heparan Sulfate Proteoglycans in Cancer Initiation and Progression
por: Nagarajan, Arvindhan, et al.
Publicado: (2018) -
Heparan sulfate proteoglycans and cancer
por: Blackhall, F H, et al.
Publicado: (2001) -
Heparan Sulfate Proteoglycans in Infection
por: Bartlett, Allison H., et al.
Publicado: (2011) -
Heparan Sulfate Proteoglycans in Tauopathy
por: Zhu, Yanan, et al.
Publicado: (2022) -
PCSK9 deficiency alters brain lipid composition without affecting brain development and function
por: Pärn, Angela, et al.
Publicado: (2023)